Related references
Note: Only part of the references are listed.Nine-gene pharmacogenomics profile service: The Mayo Clinic experience
Eric T. Matey et al.
PHARMACOGENOMICS JOURNAL (2022)
Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study
Karen M. Meagher et al.
PATIENT EDUCATION AND COUNSELING (2021)
Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison
Dyson T. Wake et al.
PHARMACOGENOMICS (2021)
North Carolina's multi-institutional pharmacogenomics efforts with the NC precision health collaborative
Jai N. Patel et al.
PHARMACOGENOMICS (2021)
Impact of Previous Genetic Counseling and Objective Numeracy on Accurate Interpretation of a Pharmacogenetics Test Report
Kelly Drelles et al.
PUBLIC HEALTH GENOMICS (2021)
Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial
John Papastergiou et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Sociodemographic factors and beliefs about medicines in the uptake of pharmacogenomic testing in older adults
Alexandra Chapdelaine et al.
PHARMACOGENOMICS (2021)
Implementation of a pharmacist-provided pharmacogenomics service in an executive health program
Ina Liko et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2021)
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
Pawel Mroz et al.
FRONTIERS IN GENETICS (2021)
Adolescent perceptions of pharmacogenetic testing
Stephani L. Stancil et al.
PHARMACOGENOMICS (2021)
Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing
Jeffrey R. Bishop
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Pharmacogenomic testing to support prescribing in primary-care: a structured review of implementation models
Judith Hayward et al.
PHARMACOGENOMICS (2021)
Pharmacogenomics education, research and clinical implementation in the state of Minnesota
Jeffrey R. Bishop et al.
PHARMACOGENOMICS (2021)
Strategies to Integrate Genomic Medicine into Clinical Care: Evidence from the IGNITE Network
Nina R. Sperber et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Patient perceptions of pharmacogenomic testing in the community pharmacy setting
David Bright et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)
Assessment of Patient Knowledge and Perceptions of Pharmacogenomics Before and After Using a Mock Results Patient Web Portal
Tien M. Truong et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
PARTICIPATORY GENOMIC TESTING CAN EFFECTIVELY DISSEMINATE CARDIOVASCULAR PHARMACOGENOMICS CONCEPTS WITHIN FEDERALLY QUALIFIED HEALTH CENTERS: A FEASIBILITY STUDY
Amber Johnson et al.
ETHNICITY & DISEASE (2020)
Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective
Tessel Rigter et al.
FRONTIERS IN GENETICS (2020)
An assessment of patient perspectives on pharmacogenomics educational materials
Gladys B. Asiedu et al.
PHARMACOGENOMICS (2020)
Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic
Meghan J. Arwood et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Pharmacogenomic (PGx) Counseling: Exploring Participant Questions about PGx Test Results
Tara Schmidlen et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Patient insights on features of an effective pharmacogenomics patient portal
Tien M. Truong et al.
PHARMACOGENETICS AND GENOMICS (2020)
Patients' Perspectives on Psychiatric Pharmacogenetic Testing
Ina Liko et al.
PHARMACOPSYCHIATRY (2020)
Practical Barriers and Facilitators Experienced by Patients, Pharmacists and Physicians to the Implementation of Pharmacogenomic Screening in Dutch Outpatient Hospital Care-An Explorative Pilot Study
Pauline Lanting et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Perspective on CYP2C19 genotyping test among patients with acute coronary syndrome - a qualitative study
Wan Yu Png et al.
FUTURE CARDIOLOGY (2020)
Updated methodological guidance for the conduct of scoping reviews
Micah D. J. Peters et al.
JBI EVIDENCE SYNTHESIS (2020)
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing
Naveen L. Pereira et al.
PHARMACOGENETICS AND GENOMICS (2019)
Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior
Larissa Waldman et al.
PHARMACOGENOMICS (2019)
Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study
Lynn G. Dressler et al.
PHARMACOGENOMICS (2019)
Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory
Susanne B. Haga et al.
PHARMACOGENOMICS (2019)
Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients
Marie-Pier Frigon et al.
PHARMACOGENOMICS (2019)
Stakeholder perspectives of the clinical utility of pharmacogenomic testing in solid organ transplantation
Kimberly M. Deininger et al.
PHARMACOGENOMICS (2019)
Description of an Established, Fee-for-Service, Office-Based, Pharmacist-Managed Pharmacogenomics Practice
Michael J. Schuh et al.
SENIOR CARE PHARMACIST (2019)
Education and Knowledge in Pharmacogenomics: Still a Challenge?
Jyothsna Giri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Developing Pharmacogenomic Reports: Insights from Patients and Clinicians
Laney K. Jones et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Patient perspectives following pharmacogenomics results disclosure in an integrated health system
Amy A. Lemke et al.
PHARMACOGENOMICS (2018)
Awareness and attitude of the public toward personalized medicine in Korea
Iyn-Hyang Lee et al.
PLOS ONE (2018)
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Andrea C. Tricco et al.
ANNALS OF INTERNAL MEDICINE (2018)
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach
Zachary Munn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2018)
Qualitative user evaluation of a revised pharmacogenetic educational toolkit
Rachel Mills et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)
Participant-perceived understanding and perspectives on pharmacogenomics: the Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time)
Janet E. Olson et al.
GENETICS IN MEDICINE (2017)
Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation
Yee Ming Lee et al.
PHARMACOGENETICS AND GENOMICS (2017)
Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay
Mara L. Gibson et al.
PHARMACOGENOMICS (2017)
Clinicians' perceptions of pharmacogenomics use in psychiatry
Christopher Yi Wen Chan et al.
PHARMACOGENOMICS (2017)
Collaborative Counseling Considerations for Pharmacogenomic Tests
Heather A. Zierhut et al.
PHARMACOTHERAPY (2017)
Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research
Aizati N. A. Daud et al.
BMC PREGNANCY AND CHILDBIRTH (2017)
Development and Initial Assessment of a Patient Education Video about Pharmacogenetics
Rachel Mills et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
Measuring genetic knowledge: a brief survey instrument for adolescents and adults
S. M. Fitzgerald-Butt et al.
CLINICAL GENETICS (2016)
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
Henry M. Dunnenberger et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2016)
Patient experiences with pharmacogenetic testing in a primary care setting
Susanne B. Haga et al.
PHARMACOGENOMICS (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Stakeholder Views on Pharmacogenomic Testing
Haridarshan N. Patel et al.
PHARMACOTHERAPY (2014)
Patients' Understanding of How Genotype Variation Affects Benefits of Tamoxifen Therapy for Breast Cancer
N. T. Brewer et al.
PUBLIC HEALTH GENOMICS (2014)
Risk, Reward, and the Double-Edged Sword: Perspectives on Pharmacogenetic Research and Clinical Testing Among Alaska Native People
Jennifer L. Shaw et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2013)
Survey of US public attitudes toward pharmacogenetic testing
S. B. Haga et al.
PHARMACOGENOMICS JOURNAL (2012)
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions
Susanne B. Haga et al.
GENETICS IN MEDICINE (2011)
Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits
P. Madadi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population
J. O'Daniel et al.
PUBLIC HEALTH GENOMICS (2010)
Consumers' views of pharmacogenetics-A qualitative study
Catherine A. Haddy et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2010)
The rapid estimate of adult literacy in genetics (REAL-G): A means to assess literacy deficits in the context of genetics
Lori H. Erby et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Share Paper
